/PRNewswire/ MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and.
By Stephen Nakrosis Shares of MIRA Pharmaceuticals are trading higher on Monday, after the company shared data on a synthetic THC analog, named MIRA1a, that.